Short answer
IRADIMED CORP (IRMD) filed its Q1 2026 10-Q quarterly report on May 1, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $22M (up 12.7% year over year) with net income of $6M.
Q1 2026 key financials · XBRL
- Revenue
- $22M
- +12.7% YoY
- Net income
- $6M
- +24.1% YoY
- Operating margin
- 32.9%
- Gross margin
- 76.5%
- EPS (diluted)
- $0.45
- +21.6% YoY
Source: XBRL data from the IRADIMED CORP (IRMD) Q1 2026 10-Q on SEC EDGAR. USD.
IRADIMED CORP Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material changes in risk factors from the 2025 Annual Report
- Carried-forward risks may adversely affect business, financial condition, or future results
- Unidentified or currently immaterial risks could materially harm future results
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other IRADIMED CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.